
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.
Orphan Drug Strategies to Help 340B Health Systems Achieve More
Date
November 01, 2023
Read time: 8 minutes
By: McKesson Health Systems Editorial Team
Orphan drugs have been making headlines for decades — not only for bringing new treatment options to patients with rare conditions and diseases, but also for notoriously high costs that are rewriting the rules for pricing, discounts, and reimbursement.
In this eBook, we’ve curated key drivers, trends, and statistics to help health systems put today’s orphan drug issues into perspective.
Download the eBook to learn how McKesson can help you achieve more for your business of pharmacy.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
Discover three key takeaways from a recent C-suite roundtable discussing the benefits and challenges of central fill for health systems.
Industry event highlights how connection, creativity, and a fresh perspective are shaping the future of health system innovation.
Our comprehensive and customizable solutions are deliberately designed with real customer challenges in mind.
McKesson’s Prateek Bhatia, VP/GM, Intrafusion, shares insights on the many opportunities health systems have with their infusion service line.
Expert insights on the rapid growth of specialty pharmacy and the importance of strategic integration.